Tamar Uziel

7.4k total citations · 1 hit paper
35 papers, 2.4k citations indexed

About

Tamar Uziel is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Tamar Uziel has authored 35 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Hematology. Recurrent topics in Tamar Uziel's work include Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Hedgehog Signaling Pathway Studies (6 papers). Tamar Uziel is often cited by papers focused on Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Hedgehog Signaling Pathway Studies (6 papers). Tamar Uziel collaborates with scholars based in United States, Israel and Australia. Tamar Uziel's co-authors include Martine F. Roussel, Richard J. Gilbertson, Yosef Shiloh, Galit Rotman, David W. Ellison, Kinneret Savitsky, Matthias Platzer, André Rosenthal, Jerold E. Rehg and Suqing Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Genes & Development.

In The Last Decade

Tamar Uziel

32 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Requirement of the MRN complex for ATM activation by DNA damage

2003 849 citations Tamar Uziel The EMBO Journal profile →

Peers

Tamar Uziel

ONCOL

GENET

René Opavský United States

Davide Danovi United Kingdom

Peter Staller Germany

Jason M. Shohet United States

Joshua M. Francis United States

Nobuyuki Onishi Japan

Alfredo Pagliuca Italy

Laura Lintault United States

Rajeev Vibhakar United States

Huai Lin United States

René Opavský United States

Tamar Uziel

1.8k ×0.9

485 ×0.6

ONCOL

554 ×0.8

174 ×0.7

GENET

130 ×0.7

GENET

Citations per year, relative to Tamar Uziel Tamar Uziel (= 1×) peers René Opavský

Countries citing papers authored by Tamar Uziel

Since Specialization

Citations

This map shows the geographic impact of Tamar Uziel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Uziel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Uziel more than expected).

Fields of papers citing papers by Tamar Uziel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamar Uziel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Uziel. The network helps show where Tamar Uziel may publish in the future.

Co-authorship network of co-authors of Tamar Uziel

This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Uziel. A scholar is included among the top collaborators of Tamar Uziel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Uziel. Tamar Uziel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stone, Jennifer D., Kamonwan Fish, Devika Ashok, et al.. (2025). ABBV-303 Is an NK-cell Engager Specific for c-Met–Expressing Tumors. Cancer Research. 86(3). 746–758.

Scott, Susan C., Anna F. Farago, W. Victoria Lai, et al.. (2025). A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 95(1). 37–37.

Plotnik, Joshua P., Irene Lee, Jacob Riehm, et al.. (2024). MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular Cancer Research. 22(8). 689–698.

Tahir, Stephen K., Emiliano Calvo, Benedito A. Carneiro, et al.. (2023). Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood. 141(17). 2114–2126. 9 indexed citations

Purcell, James W., Jonathan A. Hickson, Melvin Fox, et al.. (2018). LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates. Cancer Research. 78(14). 4059–4072. 136 indexed citations

Wang, Rui, Yupeng He, Ziping Yang, et al.. (2018). Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Molecular Cancer Therapeutics. 17(12). 2543–2550. 46 indexed citations

Lam, Lloyd T., Xiaoyu Lin, Emily J. Faivre, et al.. (2017). Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors. Molecular Cancer Therapeutics. 16(8). 1511–1520. 55 indexed citations

Boghaert, Erwin R., Xin Lü, Paul Hessler, et al.. (2017). The Volume of Three-Dimensional Cultures of Cancer Cells In Vitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors. Neoplasia. 19(9). 695–706. 25 indexed citations

Faivre, Emily J., Denise Wilcox, Xia Li, et al.. (2016). Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075. Molecular Cancer Research. 15(1). 35–44. 53 indexed citations

10.

Lin, Xiaoyu, Xiaoli Huang, Tamar Uziel, et al.. (2016). HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues. Molecular Cancer Therapeutics. 16(2). 388–396. 45 indexed citations

11.

Kawauchi, Daisuke, Giles Robinson, Tamar Uziel, et al.. (2012). A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma. Cancer Cell. 21(2). 168–180. 205 indexed citations

12.

Roberts, Lisa, et al.. (2010). Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines. Oncogene. 30(16). 1963–1968. 126 indexed citations

13.

Uziel, Tamar, Fedor V. Karginov, Amar Gajjar, et al.. (2009). The miR-17 similar to 92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory). 1 indexed citations

14.

Zindy, Frédérique, Tamar Uziel, Olivier Ayrault, et al.. (2007). Genetic Alterations in Mouse Medulloblastomas and Generation of Tumors De novo from Primary Cerebellar Granule Neuron Precursors. Cancer Research. 67(6). 2676–2684. 57 indexed citations

15.

Uziel, Tamar, Frédérique Zindy, Charles J. Sherr, & Martine F. Roussel. (2006). The CDK Inhibitor p18Ink4c is a Tumor Suppressor in Medulloblastoma. Cell Cycle. 5(4). 363–365. 26 indexed citations

16.

Uziel, Tamar, Frédérique Zindy, Suqing Xie, et al.. (2005). The tumor suppressorsInk4candp53collaborate independently withPatchedto suppress medulloblastoma formation. Genes & Development. 19(22). 2656–2667. 124 indexed citations

17.

Uziel, Tamar. (2003). Requirement of the MRN complex for ATM activation by DNA damage. The EMBO Journal. 22(20). 5612–5621. 849 indexed citations breakdown →

18.

Gatei, Magtouf, Dganit Shkedy, Kum Kum Khanna, et al.. (2001). Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by α-lipoic acid. Oncogene. 20(3). 289–294. 58 indexed citations

19.

Uziel, Tamar, Kinneret Savitsky, Matthias Platzer, et al.. (1996). Genomic Organization of the ATM Gene. Genomics. 33(2). 317–320. 135 indexed citations

20.

Savitsky, Kinneret, Yael Ziv, Anat Bar‐Shira, et al.. (1996). A Human Gene (DDX10) Encoding a Putative DEAD-Box RNA Helicase at 11q22–q23. Genomics. 33(2). 199–206. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact